Molecular pathogenesis of tuber formation in tuberous sclerosis complex
- PMID: 15563019
- DOI: 10.1177/08830738040190091301
Molecular pathogenesis of tuber formation in tuberous sclerosis complex
Abstract
Tuberous sclerosis complex results from mutations in the TSC1 (hamartin) and TSC2 (tuberin) genes. Tubers are cortical developmental malformations in patients with tuberous sclerosis complex that are associated with intractable epilepsy and are composed of histologically distinct cell types, including giant cells and dysplastic neurons. We recently showed that tubers can be dynamic lesions characterized by populations of cells undergoing proliferation, migration, and death. We demonstrate that there is cell-specific activation of the mammalian target of rapamycin (mTOR)/p70S6 kinase/ribosomal S6 cascade in tubers and that giant cells express activated (phosphorylated) p70S6 kinase and ribosomal S6 protein. These findings support impaired hamartin- and tuberin-mediated mTOR pathway regulation. Tubers likely form by constitutive activation of the mTOR cascade during brain development as a consequence of impaired hamartin or tuberin function.
Similar articles
-
Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.J Neuropathol Exp Neurol. 2004 Dec;63(12):1236-42. doi: 10.1093/jnen/63.12.1236. J Neuropathol Exp Neurol. 2004. PMID: 15624760
-
Tumor-promoting phorbol esters and activated Ras inactivate the tuberous sclerosis tumor suppressor complex via p90 ribosomal S6 kinase.Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13489-94. doi: 10.1073/pnas.0405659101. Epub 2004 Sep 1. Proc Natl Acad Sci U S A. 2004. PMID: 15342917 Free PMC article.
-
Tuberous sclerosis as an underlying basis for infantile spasm.Int Rev Neurobiol. 2002;49:315-32. doi: 10.1016/s0074-7742(02)49019-8. Int Rev Neurobiol. 2002. PMID: 12040899 Review.
-
Mouse models of tuberous sclerosis complex.J Child Neurol. 2004 Sep;19(9):726-33. doi: 10.1177/08830738040190091401. J Child Neurol. 2004. PMID: 15563020 Review.
-
Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling.Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13571-6. doi: 10.1073/pnas.202476899. Epub 2002 Sep 23. Proc Natl Acad Sci U S A. 2002. PMID: 12271141 Free PMC article.
Cited by
-
Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement.Nat Commun. 2016 Jun 1;7:11753. doi: 10.1038/ncomms11753. Nat Commun. 2016. PMID: 27249187 Free PMC article.
-
Multiple Critical Periods for Rapamycin Treatment to Correct Structural Defects in Tsc-1-Suppressed Brain.Front Mol Neurosci. 2018 Nov 8;11:409. doi: 10.3389/fnmol.2018.00409. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30467464 Free PMC article.
-
Insights into Tuberous Sclerosis Complex : From Genes to Clinics.J Korean Neurosurg Soc. 2025 May;68(3):321-337. doi: 10.3340/jkns.2025.0035. Epub 2025 Mar 14. J Korean Neurosurg Soc. 2025. PMID: 40090343 Free PMC article.
-
Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.Neurobiol Dis. 2012 Jan;45(1):369-80. doi: 10.1016/j.nbd.2011.08.024. Epub 2011 Aug 26. Neurobiol Dis. 2012. PMID: 21907282 Free PMC article.
-
Longitudinal CT and MR appearances of hemimegalencephaly in a patient with tuberous sclerosis.Childs Nerv Syst. 2008 Mar;24(3):397-401. doi: 10.1007/s00381-007-0463-x. Epub 2007 Sep 18. Childs Nerv Syst. 2008. PMID: 17876590
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous